Background 20resize
Cover 20image 20compressed

Endomedix, Inc.

Company has developed patented device for brain & spine surgery that can reduce major complications and save hospitals thousands in direct costs per case.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Montclair, NJ, US
  • Currency USD
  • Founded July 2014
  • Employees 3
  • Incorporation Type C-corp
  • Website endomedix.com

Company Summary

Endomedix is a MedTech venture creating breakthrough devices to transform biosurgery & other medical applications. Our first device, PlexiClot™ Absorbable Hemostat is poised to become best in class for bleeding control in brain & spine surgeries, a $1.8B market. PlexiClot is validated in in vivo trials & protected by 10 issued patents. Currently preparing scaling up at CDMO. Company has been funded by $3M in NIH grants & $4M in private capital.

Team

  • 35+ years in history. Veteran of 2 early stage MedTech ventures w/successful exits. Hands-on leader with strong general management, sales & marketing, international, new products clinical trial and regulatory affairs experience. Successfully obtained 2 FDA PMA & 1 CE mark approvals. Lead cash investor in Endomedix.

  • 8f43d4a1 4f31 45b2 984e b41401d44741
    Vice President - Research & Development

    Solid development experience, led creation of new patented chemistry. Developed breakthrough techniques for biopolymer processing. Lead inventor on patents & author of ground breaking scientific publications. Effective at leading & coordinating world class team of subject matter experts in fields of biopolymer design, chemical engineering, chemometrics.

  • E7456a60 a518 4862 9029 96f0478c4d3e
    Scientist

    Biopolymer processing of starting materials. Functional tresting of hydrogel protoypes formed by biopolymer precursors. Data analysis.

  • Default avatar
    Michael Jaffe, PhD
    Polymer Chemistry Research

    World renown polymer expert. Past chair, Polymeric Materials, Science & Engineering Division of American Chemical Society; Editor of "Polymers for Advanced Technologies, 1989-2001. Thomas Alva Edison Patent Award - 1995, 2011; North American Thermal Analysis Society Lifetime Achievement Award - 2010; Fellow-American Association for the Advancement of Science - 1993

  • 9027633d b320 4b55 bb8c 65adafd5f043
    Organic Chemistry Scientist

    Allied Signal Inc. -Research, Advanced Molecular Modeling and Computational Chemistry Applications; Group Leader-Nuclear Magnetic Resonance; High Performance Computing.
    Hoechst Research and Technology-Scientist, NMR Spectroscopy
    Yale University, Department of Chemistry-Assistant Professor of Chemistry
    BA, Chemistry-Northwestern University; PhD & MS-Organic Chemistry-Columbia University; NIH Post Doctoral Fellow-California Institute of Technology.

  • Default avatar
    Thomas Gsell, PhD
    Chemical Engineering

    Ret: Sr Corp VP-R&D, Pall Corporation. Key member of Pall Medical Business Unit launched platform of successful blood filtration products aimed at removing white blood cells from transfused blood. Co-inventor on 100+ issued and Published US and International patents, as well as a number of peer-reviewed scientific publications.
    BS Chemistry-SUNY Albany; MS Polymer Chemistry-Florida State University; PhD Polymer Sciences - Polytechnic University.

Advisors

  • Default avatar
    William Cobb MD, PhD
    Unconfirmed
    Default avatar
    Neil R. Malhotra, MD
    Unconfirmed
    Default avatar
    Anthony D' Ambrosio, MD
    Unconfirmed

Previous Investors

  • Default avatar
    Barry Krosser, MD
    Unconfirmed
    Default avatar
    William Leahy, MD
    Unconfirmed
  • Default avatar
    Richard Levy, MD
    Unconfirmed
    Default avatar
    Weiliam Chen, Ph.D
    Unconfirmed
  • Default avatar
    Anthony D'Ambrosio, MD
    Unconfirmed
  • Default avatar
    Richard Russo
    Unconfirmed
    Default avatar
    David Foster
    Unconfirmed
    Default avatar
    William Goldstein, MD
    Unconfirmed
  • Default avatar
    Barry Krosser, MD
    Unconfirmed
    Default avatar
    James Pastena
    Unconfirmed
    Default avatar
    Tony Dimun
    Unconfirmed
  • Default avatar
    Steve Levy &
    Unconfirmed
    Default avatar
    Gaetan Moise MD
    Unconfirmed
    Default avatar
    John M Abrahams MD
    Unconfirmed
  • Default avatar
    Lateral Capital Management LLC
    Unconfirmed
    Default avatar
    Mark Kelliher
    Unconfirmed
  • Default avatar
    Laurence L Betterley
    Unconfirmed
    Default avatar
    Milind Thamke
    Unconfirmed
  • Default avatar
    Joseph Comisio DDS
    Unconfirmed
    Default avatar
    Yvonne Figarella MD
    Unconfirmed